Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension
R. Lewis (Sheffield (South Yorkshire), United Kingdom), A. Thompson (Sheffield (South Yorkshire), United Kingdom), C. Billings (Sheffield (South Yorkshire), United Kingdom), A. Charalampopoulos (Sheffield (South Yorkshire), United Kingdom), C. Elliot (Sheffield (South Yorkshire), United Kingdom), N. Hamilton (Sheffield (South Yorkshire), United Kingdom), C. Hill (Sheffield (South Yorkshire), United Kingdom), J. Hurdman (Sheffield (South Yorkshire), United Kingdom), S. Rajaram (Sheffield (South Yorkshire), United Kingdom), I. Sabroe (Sheffield (South Yorkshire), United Kingdom), A. Swift (Sheffield (South Yorkshire), United Kingdom), D. Kiely (Sheffield (South Yorkshire), United Kingdom), R. Condliffe (Sheffield (South Yorkshire), United Kingdom)
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Session: Pulmonary hypertension in lung diseases
Session type: E-poster session
Number: 290
Disease area: Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Lewis (Sheffield (South Yorkshire), United Kingdom), A. Thompson (Sheffield (South Yorkshire), United Kingdom), C. Billings (Sheffield (South Yorkshire), United Kingdom), A. Charalampopoulos (Sheffield (South Yorkshire), United Kingdom), C. Elliot (Sheffield (South Yorkshire), United Kingdom), N. Hamilton (Sheffield (South Yorkshire), United Kingdom), C. Hill (Sheffield (South Yorkshire), United Kingdom), J. Hurdman (Sheffield (South Yorkshire), United Kingdom), S. Rajaram (Sheffield (South Yorkshire), United Kingdom), I. Sabroe (Sheffield (South Yorkshire), United Kingdom), A. Swift (Sheffield (South Yorkshire), United Kingdom), D. Kiely (Sheffield (South Yorkshire), United Kingdom), R. Condliffe (Sheffield (South Yorkshire), United Kingdom). Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension. 290
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: